Holy Name Medical Center announced its new partnership with Sharsheret®, a national organization supporting Jewish women and their families at high risk for or diagnosed with breast or ovarian cancer. The unique collaboration will provide a wealth of resources for patients, including connections with health professionals and peers, critical conversations with genetic specialists and psychosocial support.
“Holy Name’s partnership with Sharsheret will enhance the education, support and amenities provided to Jewish women facing breast and ovarian cancer in ways that go far beyond traditional health care,” said Michael Maron, president and CEO of Holy Name. “Founded in Teaneck, Sharsheret has a dynamic support network in the North Jersey community and an outstanding national reputation of supporting Jewish women facing breast and ovarian cancer. This new partnership is a natural fit for us, as we continue to provide high-quality, culturally relevant health care to the many diverse patient groups in our community.”
Holy Name, a national model for providing culturally and linguistically sensitive care to all patients, currently offers a multitude of services through Cancer Support Community, formerly Gilda’s Club. Staff, professionals and volunteers offer educational classes and activities such as jewelry making, tango classes and yoga sessions to anyone who has been impacted by cancer, regardless of where they received treatment. Additionally, Holy Name was recently selected as one of the state’s “Population Health Heroes” for its commitment to serve diverse communities.
“Working together with Holy Name Medical Center, we understand first-hand the importance of providing the highest level of care while being intimately knowledgeable about the unique issues and concerns of each and every patient,” said Sharsheret Executive Director Elana Silber. “Our partnership serves as a model of true patient-centered care, support and education that will improve the quality of life for thousands of local Jewish women and families facing breast and ovarian cancer.”
Through the Sharsheret partnership, women and their families can now also access information to better understand their individual circumstances, cope with unique challenges and make informed decisions about treatment. In addition, specialized support is available for women living with metastatic or advanced breast and ovarian cancer. Patients and families of all backgrounds are welcome at any point in the cancer journey.
